BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21668904)

  • 1. Augmented cross-sectional studies with abbreviated follow-up for estimating HIV incidence.
    Claggett B; Lagakos SW; Wang R
    Biometrics; 2012 Mar; 68(1):62-74. PubMed ID: 21668904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented cross-sectional prevalence testing for estimating HIV incidence.
    Wang R; Lagakos SW
    Biometrics; 2010 Sep; 66(3):864-74. PubMed ID: 19912174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the use of adjusted cross-sectional estimators of HIV incidence.
    Wang R; Lagakos SW
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):538-47. PubMed ID: 19881357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical considerations for cross-sectional HIV incidence estimation based on recency test.
    Gao F; Bannick M
    Stat Med; 2022 Apr; 41(8):1446-1461. PubMed ID: 34984710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new general biomarker-based incidence estimator.
    Kassanjee R; McWalter TA; Bärnighausen T; Welte A
    Epidemiology; 2012 Sep; 23(5):721-8. PubMed ID: 22627902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size methods for estimating HIV incidence from cross-sectional surveys.
    Konikoff J; Brookmeyer R
    Biometrics; 2015 Dec; 71(4):1121-9. PubMed ID: 26302040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating HIV incidence based on combined prevalence testing.
    Balasubramanian R; Lagakos SW
    Biometrics; 2010 Mar; 66(1):1-10. PubMed ID: 19397583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities.
    Xu Y; Laeyendecker O; Wang R
    Biometrics; 2019 Sep; 75(3):1017-1028. PubMed ID: 30746695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design.
    Molebatsi K; Gabaitiri L; Mokgatlhe L; Moyo S; Gaseitsiwe S; Wirth KE; DeGruttola V; Tchetgen Tchetgen E
    Stat Med; 2020 Oct; 39(24):3255-3271. PubMed ID: 32875624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BED estimates of HIV incidence: resolving the differences, making things simpler.
    Hargrove J; van Schalkwyk C; Eastwood H
    PLoS One; 2012; 7(1):e29736. PubMed ID: 22235334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enhanced cross-sectional HIV incidence estimator that incorporates prior HIV test results.
    Bannick M; Donnell D; Hayes R; Laeyendecker O; Gao F
    Stat Med; 2024 May; ():. PubMed ID: 38803064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the distribution of a renewal process from times at which events from an independent process are detected.
    Song R; Karon JM; White E; Goldbaum G
    Biometrics; 2006 Sep; 62(3):838-46. PubMed ID: 16984327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Monte Carlo evaluation of five interval estimators for the relative risk in sparse data.
    Lui KJ
    Biom J; 2006 Feb; 48(1):131-43. PubMed ID: 16544818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based study of fertility in women with HIV-1 infection in Uganda.
    Gray RH; Wawer MJ; Serwadda D; Sewankambo N; Li C; Wabwire-Mangen F; Paxton L; Kiwanuka N; Kigozi G; Konde-Lule J; Quinn TC; Gaydos CA; McNairn D
    Lancet; 1998 Jan; 351(9096):98-103. PubMed ID: 9439494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of multistage pooling studies of biological specimens for estimating disease incidence and prevalence.
    Brookmeyer R
    Biometrics; 1999 Jun; 55(2):608-12. PubMed ID: 11318222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the infection time and latency distribution of AIDS with doubly censored data.
    Gómez G; Lagakos SW
    Biometrics; 1994 Mar; 50(1):204-12. PubMed ID: 8086603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods.
    Sweeting MJ; De Angelis D; Parry J; Suligoi B
    Stat Med; 2010 Dec; 29(30):3194-202. PubMed ID: 21170913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the statistical accuracy of biomarker assays for HIV incidence.
    Brookmeyer R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):406-14. PubMed ID: 20436353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating HIV incidence from age-specific prevalence data: comparison with concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe.
    Gregson S; Machekano R; Donnelly CA; Mbizvo MT; Anderson RM; Katzenstein DA
    AIDS; 1998 Oct; 12(15):2049-58. PubMed ID: 9814874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating marker-based incidence estimates in repeatedly screened populations.
    Satten GA; Janssen R; Busch MP; Datta S
    Biometrics; 1999 Dec; 55(4):1224-7. PubMed ID: 11315072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.